J. Schapiro: Prioritizing Resistance in Future Antiretroviral Therapy
Jonathan M. Schapiro MD, is Clinical Assistant Professor at Stanford University School of Medicine, Stanford, California, and Director of the AIDS Service, National Hemophilia Center, at Sheba Medical Center, Sackler School of Medicine, Tel Aviv University, Israel. Dr Schapiro received his medical degree from Ben Gurion University of the Negev Medical School Israel,
Dr Schapiro’s work has focused on the study of resistance and cross-resistance between protease inhibitors and the clinical utility of resistance assays. His publications have studied the clinical utility of salvage therapy, the mutational correlates of drug failure and clinical use of genotypic resistance testing. He is also very active in educational initiatives. He codirects the Stanford University HIV Medicine Course and is involved in numerous programs for AIDS-treating physicians.
Dr Schapiro currently shares his time among research, clinical and educational activities in Israel, Europe and the United States.